These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2899720)

  • 1. Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation.
    O'Grady JG; Alexander GJ; Sutherland S; Donaldson PT; Harvey F; Portmann B; Calne RY; Williams R
    Lancet; 1988 Aug; 2(8606):302-5. PubMed ID: 2899720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus infection does not increase the risk of vanishing bile duct syndrome after liver transplantation.
    van den Berg AP; Klompmaker IJ; Hepkema BG; Gouw AS; Haagsma EB; Lems SP; The TH; Slooff MJ
    Transpl Int; 1996; 9 Suppl 1():S171-3. PubMed ID: 8959818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of association between cytomegalovirus infection, HLA matching and the vanishing bile duct syndrome after liver transplantation.
    Paya CV; Wiesner RH; Hermans PE; Larson-Keller JJ; Ilstrup DM; Krom RA; Moore SB; Ludwig J; Smith TF
    Hepatology; 1992 Jul; 16(1):66-70. PubMed ID: 1319956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation.
    Mañez R; White LT; Linden P; Kusne S; Martin M; Kramer D; Demetris AJ; Van Thiel DH; Starzl TE; Duquesnoy RJ
    Transplantation; 1993 May; 55(5):1067-71. PubMed ID: 8388584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus infection in renal transplant recipients: one center's experience.
    Bal Z; Uyar ME; Tutal E; Erdogan E; Colak T; Sezer S; Haberal M
    Transplant Proc; 2013; 45(10):3520-3. PubMed ID: 24314948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between HLA tissue type, CMV infection, and acute graft-vs-host disease after allogeneic hematopoietic stem cell transplantation: single-center experience.
    Kekik C; Besisik SK; Seyhun Y; Oguz FS; Sargin D; Carin MN
    Transplant Proc; 2009 Nov; 41(9):3859-62. PubMed ID: 19917401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of donor/recipient human leukocyte antigen mismatch on human cytomegalovirus replication following liver transplantation.
    Aldridge RW; Mattes FM; Rolando N; Rolles K; Smith C; Shirling G; Atkinson C; Burroughs AK; Milne RS; Emery VC; Griffiths PD
    Transpl Infect Dis; 2015 Feb; 17(1):25-32. PubMed ID: 25572799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of partial HLA class I match on acute rejection in viral pre-infected human liver allograft recipients.
    Ontañón J; Muro M; García-Alonso AM; Minguela A; Torío A; Bermejo J; Pons JA; Campos M; Alvarez-López MR
    Transplantation; 1998 Apr; 65(8):1047-53. PubMed ID: 9583864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic alpha-interferon expression in cytomegalovirus-infected liver allograft recipients with and without vanishing bile duct syndrome.
    Arnold JC; Nouri-Aria KT; O'Grady JG; Portmann BC; Alexander GJ; Williams R
    Clin Investig; 1993 Mar; 71(3):191-6. PubMed ID: 8386961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of human leukocyte antigen matching on liver allograft survival and rejection: "the dualistic effect".
    Donaldson P; Underhill J; Doherty D; Hayllar K; Calne R; Tan KC; O'Grady J; Wight D; Portmann B; Williams R
    Hepatology; 1993 Jun; 17(6):1008-15. PubMed ID: 8514248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus infection as a possible risk factor for ductopenic rejection (vanishing bile duct syndrome) after liver transplantation.
    Hoffmann RM; Günther C; Diepolder HM; Zachoval R; Eissner HJ; Forst H; Anthuber M; Paumgartner G; Pape GR
    Transpl Int; 1995; 8(5):353-9. PubMed ID: 7576016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of HLA compatibility on cytomegalovirus infection in kidney transplantation].
    Pouteil-Noble C; Bétuel H; Raffaele P; Megri K; Louvier C; Lefrançois N; Bosshard S; Dubernard JM; Aymard M; Touraine JL
    Presse Med; 1991 Nov; 20(40):2022-4. PubMed ID: 1662376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex mismatch as a risk factor for chronic rejection of liver allografts.
    Candinas D; Gunson BK; Nightingale P; Hubscher S; McMaster P; Neuberger JM
    Lancet; 1995 Oct; 346(8983):1117-21. PubMed ID: 7475600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent cytomegalovirus in liver allografts with chronic rejection.
    Lautenschlager I; Höckerstedt K; Jalanko H; Loginov R; Salmela K; Taskinen E; Ahonen J
    Hepatology; 1997 Jan; 25(1):190-4. PubMed ID: 8985289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of positive lymphocyte crossmatch and HLA mismatching on vanishing bile duct syndrome in human liver allografts.
    Batts KP; Moore SB; Perkins JD; Wiesner RH; Grambsch PM; Krom RA
    Transplantation; 1988 Feb; 45(2):376-9. PubMed ID: 3278430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An association between cytomegalovirus infection and chronic rejection after liver transplantation.
    Evans PC; Soin A; Wreghitt TG; Taylor CJ; Wight DG; Alexander GJ
    Transplantation; 2000 Jan; 69(1):30-5. PubMed ID: 10653376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for an immune response to HLA class I antigens in the vanishing-bileduct syndrome after liver transplantation.
    Donaldson PT; Alexander GJ; O'Grady J; Neuberger J; Portmann B; Thick M; Davis H; Calne RY; Williams R
    Lancet; 1987 Apr; 1(8539):945-51. PubMed ID: 2882341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Human Leukocyte Antigen Compatibility in Graft Outcomes After Living Donor Liver Transplantation.
    Shin M; Kim JM; Kwon CH; Kim SJ; Joh JW
    Transplant Proc; 2016 May; 48(4):1123-9. PubMed ID: 27320571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus infection is associated with increased inflammation and severe bile duct damage in rat liver allografts.
    Martelius T; Krogerus L; Höckerstedt K; Bruggeman C; Lautenschlager I
    Hepatology; 1998 Apr; 27(4):996-1002. PubMed ID: 9537439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of human cytomegalovirus viremia with human leukocyte antigens in liver transplantation recipients.
    Hu J; Meng X; Zhao H; Zhang X; Gao H; Yang M; Ma Y; Li M; Ma W; Fan J
    Acta Biochim Biophys Sin (Shanghai); 2011 Jul; 43(7):576-81. PubMed ID: 21680603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.